Moreover, Kaplanov et al. (2019) [26] showed that IL-1β knockout mice, when engrafted with breast cancer cells, had initial tumor growth followed by regression, due to a shift in the immune infiltrate. This evidence concerns the gene IL1B and breast carcinoma.